1 week Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal The Wall Street Journal
Pharmaceutical giants have recently shown new enthusiasm for mental-health treatments with vast but unrealized promise.
Health · Johnson & Johnson (JNJ)
X